415 related articles for article (PubMed ID: 19502782)
21. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
22. p53 regulates cellular responses to environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells.
Xiao H; Singh SV
Cell Cycle; 2007 Jul; 6(14):1753-61. PubMed ID: 17630511
[TBL] [Abstract][Full Text] [Related]
23. Naphthalimides induce G(2) arrest through the ATM-activated Chk2-executed pathway in HCT116 cells.
Zhu H; Miao ZH; Huang M; Feng JM; Zhang ZX; Lu JJ; Cai YJ; Tong LJ; Xu YF; Qian XH; Ding J
Neoplasia; 2009 Nov; 11(11):1226-34. PubMed ID: 19881958
[TBL] [Abstract][Full Text] [Related]
24. 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.
Tse AN; Sheikh TN; Alan H; Chou TC; Schwartz GK
Mol Pharmacol; 2009 Jan; 75(1):124-33. PubMed ID: 18820127
[TBL] [Abstract][Full Text] [Related]
25. P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells.
Chen L; Jiang J; Cheng C; Yang A; He Q; Li D; Wang Z
Cancer Biol Ther; 2007 Jun; 6(6):965-73. PubMed ID: 17534142
[TBL] [Abstract][Full Text] [Related]
26. The radiomimetic enediyne C-1027 induces unusual DNA damage responses to double-strand breaks.
Kennedy DR; Beerman TA
Biochemistry; 2006 Mar; 45(11):3747-54. PubMed ID: 16533058
[TBL] [Abstract][Full Text] [Related]
27. Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation.
Turner J; Koumenis C; Kute TE; Planalp RP; Brechbiel MW; Beardsley D; Cody B; Brown KD; Torti FM; Torti SV
Blood; 2005 Nov; 106(9):3191-9. PubMed ID: 16014567
[TBL] [Abstract][Full Text] [Related]
28. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
[TBL] [Abstract][Full Text] [Related]
29. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
[TBL] [Abstract][Full Text] [Related]
30. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
[TBL] [Abstract][Full Text] [Related]
31. Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway.
Yamane K; Taylor K; Kinsella TJ
Biochem Biophys Res Commun; 2004 May; 318(1):297-302. PubMed ID: 15110787
[TBL] [Abstract][Full Text] [Related]
32. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
Chen JS; Lin SY; Tso WL; Yeh GC; Lee WS; Tseng H; Chen LC; Ho YS
Mol Carcinog; 2006 Jul; 45(7):461-78. PubMed ID: 16649252
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of CHK1 kinase by Gö6976 converts 8-chloro-adenosine-induced G2/M arrest into S arrest in human myelocytic leukemia K562 cells.
Jia XZ; Yang SY; Zhou J; Li SY; Ni JH; An GS; Jia HT
Biochem Pharmacol; 2009 Mar; 77(5):770-80. PubMed ID: 19059218
[TBL] [Abstract][Full Text] [Related]
34. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C.
Singh SV; Herman-Antosiewicz A; Singh AV; Lew KL; Srivastava SK; Kamath R; Brown KD; Zhang L; Baskaran R
J Biol Chem; 2004 Jun; 279(24):25813-22. PubMed ID: 15073169
[TBL] [Abstract][Full Text] [Related]
35. Lidamycin regulates p53 expression by repressing Oct4 transcription.
Zhen HY; Zhou J; Wu HN; Yao C; Zhang T; Wu T; Quan CS; Li YL
Biochem Biophys Res Commun; 2014 May; 447(2):224-30. PubMed ID: 24709078
[TBL] [Abstract][Full Text] [Related]
36. Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERK1/2 and Chk1 kinase activation.
Chou YH; Ho YS; Wu CC; Chai CY; Chen SC; Lee CH; Tsai PS; Wu CH
Food Chem Toxicol; 2007 Aug; 45(8):1356-67. PubMed ID: 17329004
[TBL] [Abstract][Full Text] [Related]
37. Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics.
Xiao Z; Xue J; Semizarov D; Sowin TJ; Rosenberg SH; Zhang H
Int J Cancer; 2005 Jul; 115(4):528-38. PubMed ID: 15688426
[TBL] [Abstract][Full Text] [Related]
38. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells.
Sahu RP; Batra S; Srivastava SK
Br J Cancer; 2009 May; 100(9):1425-33. PubMed ID: 19401701
[TBL] [Abstract][Full Text] [Related]
39. Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints.
Tao Y; Leteur C; Yang C; Zhang P; Castedo M; Pierré A; Golsteyn RM; Bourhis J; Kroemer G; Deutsch E
Cell Cycle; 2009 Apr; 8(8):1196-205. PubMed ID: 19305158
[TBL] [Abstract][Full Text] [Related]
40. DNA replication stress in CHK1-depleted tumour cells triggers premature (S-phase) mitosis through inappropriate activation of Aurora kinase B.
Zuazua-Villar P; Rodriguez R; Gagou ME; Eyers PA; Meuth M
Cell Death Dis; 2014 May; 5(5):e1253. PubMed ID: 24853431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
